On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Nature Reviews Drug Discovery

JournalCitation impact & published research

Nature Reviews Drug Discovery is a journal indexed in ScholarIQ from OpenAlex.

How many works does Nature Reviews Drug Discovery have?

ScholarIQindexed works

Nature Reviews Drug Discovery has 6,869 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Nature Reviews Drug Discovery have?

ScholarIQcitation count

Nature Reviews Drug Discovery has 782,363 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Nature Reviews Drug Discovery?

ScholarIQh-index

Nature Reviews Drug Discovery has an h-index of 476 in OpenAlex.

What is the OpenAlex record for Nature Reviews Drug Discovery?

ScholarIQopenalex

The OpenAlex for Nature Reviews Drug Discovery is on the source record.

What are the most-cited papers on Nature Reviews Drug Discovery?

ScholarIQmost cited works
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov, Sergey B. Zotchev, Verena M. Dirsch, the International Natural Product Sciences Taskforce, İlkay Erdoğan Orhan, Maciej Banach, Judith M. Rollinger, Davide Barreca, Wolfram Weckwerth, Rudolf Bauer, Edward A. Bayer, Muhammed Majeed, Anupam Bishayee, Valery N. Bochkov, Günther K. Bonn, Nady Braidy, Franz Bučar, Alejandro Cifuentes, Grazia D’Onofrio, Michael J. Bodkin, Marc Diederich, Albena T. Dinkova‐Kostova, Thomas Efferth, Khalid El Bairi, Nicolas Arkells, Tai-Ping Fan, Bernd L. Fiebich, Michael Freissmuth, Milen I. Georgiev, Simon Gibbons, Keith M. Godfrey, Christian W. Gruber, Jag Heer, Lukas A. Huber, Elena Ibáñez, Anake Kijjoa, Anna K. Kiss, Aiping Lü, Francisco A. Macı́as, Mark J.S. Miller, Andrei Mocan, Rolf Müller, Ferdinando Nicoletti, George Perry, Valeria Pittalà, Luca Rastrelli, Michael Ristow, Gian Luigi Russo, A. Sanches‐Silva, Daniela Schuster, Helen Sheridan, Krystyna Skalicka‐Woźniak, Léandros Skaltsounis, Eduardo Sobarzo‐Sánchez, David S. Bredt, Hermann Stuppner, Antoni Sureda, Nikolay Tzvetkov, Rosa Anna Vacca, Bharat B. Aggarwal, Maurizio Battino, Francesca Giampieri, Michaël Wink, Jean‐Luc Wolfender, Jianbo Xiao, Andy Wai Kan Yeung, Gérard Lizard, Michael Popp, Michael Heinrich, Ioana Berindan-Neagoe, Marc Stadler, Maria Daglia, Robert Verpoorte, Claudiu T. Supuran
Nature Reviews Drug Discovery. 20215,183 CitationsOPEN ACCESS
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow
Nature Reviews Drug Discovery. 2020938 CitationsOPEN ACCESS
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel, Richard Frank, Karl Broich, Stefan Teipel, Russell Katz, John Hardy, Karl Herholz, Arun L.W. Bokde, Frank Jessen, Yvonne C. Hoessler, Wendy R. Sanhai, Henrik Zetterberg, Janet Woodcock, Kaj Blennow
Nature Reviews Drug Discovery. 2010633 Citations
Complement, a target for therapy in inflammatory and degenerative diseases
B. Paul Morgan, Claire L. Harris
Nature Reviews Drug Discovery. 2015430 CitationsOPEN ACCESS
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Elizabeth Berry‐Kravis, Lothar Lindemann, Aia Elise Jønch, George Apostol, Mark F. Bear, Randall L. Carpenter, Jacqueline N. Crawley, Aurore Curie, Vincent des Portes, Farah Hossain, F. Gasparini, Baltazar Gomez‐Mancilla, David Hessl, Eva Loth, Sebastian H. Scharf, Paul P. Wang, Florian von Raison, Randi J. Hagerman, Will Spooren, Sébastien Jacquemont
Nature Reviews Drug Discovery. 2017356 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial